About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Georgia | 476 Studies

Clinical Trials LymphomaGeorgia

Lymphoma Clinical Trials in Georgia

Find 476 clinical trials for lymphoma near Georgia. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 421-440 of 476 trials

RecruitingA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasThe purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of…NCT04104776·Tampa, Florida and 79 others

PreviousPage 22 of 24Next

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesThe purpose of this signal seeking study is to determine whether treatment with PDR001 and LAG525 demonstrates sufficient efficacy in advanced malignancies to warrant further…NCT03365791·San Francisco, California and 19 others

CompletedA Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaThis is a Phase 1, open-label, multicenter study evaluating the safety, pharmacokinetic profile, and preliminary efficacy of ABT-199 in combination with Bendamustine/Rituximab in…NCT01594229·La Jolla, California and 7 others

CompletedReduced Intensity Conditioning Transplant Using Haploidentical DonorsThis trial will evaluate the safety and efficacy of a reduced intensity allogeneic HSCT from partially HLA-mismatched first-degree relatives utilizing PBSC as the stem cell source.NCT02581007·Atlanta, Georgia

RecruitingOpen-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone LymphomaThe purpose of this research study is to see if loncastuximab tesirine has any benefits at dose levels researchers found acceptable in earlier studies in patients with related…NCT05296070·Duarte, California and 3 others

TerminatedA Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid TumorsThis study is a dose escalation, and cohort expansion study in subjects with advanced cancer for which no standard therapy exists.NCT02440685·Tempe, Arizona and 13 others

Active not recruitingBendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell LymphomaThis phase II trial studies how well bendamustine, obinutuzumab, and venetoclax work in treating patients with mantle cell lymphoma.NCT03872180·Atlanta, Georgia and 2 others

CompletedA Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersThis is an open-label, multicenter, Phase 1/2 study of the CTLA-4 antibody, tremelimumab, and the PD-L1 antibody, durvalumab (MEDI4736), in combination with the tumor…NCT02643303·Atlanta, Georgia and 6 others

TerminatedGEN3014 Trial in Relapsed or Refractory Hematologic MalignanciesThe drug that will be investigated in the study is an antibody, GEN3014. Since this is the first study of GEN3014 in humans, the main purpose is to evaluate safety.NCT04824794·Hackensack, New Jersey and 51 others

CompletedUse of Topotecan in Patients With Refractory Acute LeukemiaThe purpose of this study is to identify the highest tolerated doses in drugs used to treat aggressive leukemia, lymphoma or multiple myeloma not responding to standard…NCT00100477·Gainesville, Florida

Active not recruitingSelpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment TrialThis phase II pediatric MATCH treatment trial studies how well selpercatinib works in treating patients with solid tumors that may have spread from where they first started to…NCT04320888·Birmingham, Alabama and 173 others

CompletedA Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)This open-label, international, multicenter study will investigate the safety and efficacy of venetoclax (GDC-0199) in combination with bendamustine plus rituximab (venetoclax +…NCT02187861·Mobile, Alabama and 70 others

Active not recruitingStudy of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive PatientsThis is a single arm, open-label, multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in de novo HR pediatric and young adult B-ALL patients who…NCT03876769·Birmingham, Alabama and 42 others

CompletedCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00002941·Birmingham, Alabama and 234 others

CompletedDose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P MutationRecent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the activated B-cell (ABC) type of Diffuse Large B…NCT02252146·Los Angeles, California and 11 others

CompletedDuvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS StudyThis early phase I trial investigates how well duvelisib exposure before CAR-T cell manufacturing works to enhance immune profiles of T cells in patients with diffuse large B-cell…NCT04890236·Atlanta, Georgia and 1 other

CompletedA Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior TreatmentThe purpose of this study is to evaluate response rate, survival, safety and tolerability of YM155 given in combination with rituximab in subjects with Non-Hodgkin's Lymphoma.NCT01007292·Columbus, Georgia and 18 others

TerminatedSafety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin LymphomaThis trial is to assess the safety \& efficacy of the Combination of Pembrolizumab and Lenalidomide in the management of patients with Relapsed Hodgkin Lymphoma.NCT02875067·Atlanta, Georgia and 2 others

CompletedA Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD.NCT05637801·Gilbert, Arizona and 67 others

CompletedA Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell LymphomaThe purpose of this study is to evaluate the activity of romidepsin in patients with progressive or relapsed peripheral T-cell lymphoma (PTCL) who have already been treated with…NCT00426764·La Jolla, California and 89 others

Other Conditions in Georgia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia